{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:49:31Z","timestamp":1759513771267,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T00:00:00Z","timestamp":1613260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T00:00:00Z","timestamp":1613260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1245\/s10434-021-09657-w","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T01:15:35Z","timestamp":1613610935000},"page":"6489-6497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Racial Differences in Response to Neoadjuvant Chemotherapy: Impact on Breast and Axillary Surgical Management"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-3663","authenticated-orcid":false,"given":"Theresa","family":"Relation","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samilia","family":"Obeng-Gyasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oindrila","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam F.","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Tsung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget A.","family":"Oppong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,14]]},"reference":[{"key":"9657_CR1","doi-asserted-by":"publisher","unstructured":"Fahad Ullah M. Breast cancer: current perspectives on the\u00a0disease status. In: Ahmad A (ed) Breast Cancer Metastasis and Drug Resistance: Challenges and Progress. Advances in Experimental Medicine and Biology. Springer International Publishing, Cham, Switzerland, 2019, pp 51\u201364. doi:https:\/\/doi.org\/10.1007\/978-3-030-20301-6_4.","DOI":"10.1007\/978-3-030-20301-6_4"},{"key":"9657_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2014.17322","volume":"313","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313:165\u201373. https:\/\/doi.org\/10.1001\/jama.2014.17322.","journal-title":"JAMA."},{"key":"9657_CR3","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1002\/cncr.29935","volume":"122","author":"DR Williams","year":"2016","unstructured":"Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: unpacking the social context. Cancer. 2016;122:2138\u201349. https:\/\/doi.org\/10.1002\/cncr.29935.","journal-title":"Cancer"},{"key":"9657_CR4","doi-asserted-by":"publisher","unstructured":"Hill DA, Prossnitz ER, Royce M, Nibbe A. Temporal trends in breast cancer survival by race and ethnicity: a population-based cohort study. PLoS ONE. 2019;14(10). https:\/\/doi.org\/10.1371\/journal.pone.0224064.","DOI":"10.1371\/journal.pone.0224064"},{"key":"9657_CR5","doi-asserted-by":"publisher","unstructured":"Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975\u20132011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107:djv048. doi:https:\/\/doi.org\/10.1093\/jnci\/djv048.","DOI":"10.1093\/jnci\/djv048"},{"key":"9657_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-20301-6_3","volume":"1152","author":"CG Yedjou","year":"2019","unstructured":"Yedjou CG, Sims JN, Miele L, et al. Health and racial disparity in breast cancer. Adv Exp Med Biol. 2019;1152:31\u201349. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_3.","journal-title":"Adv Exp Med Biol."},{"key":"9657_CR7","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1200\/JCO.2017.77.6310","volume":"36","author":"SB Wheeler","year":"2018","unstructured":"Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Hayes KE. Financial impact of breast cancer in black versus white women. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36:1695\u2013701. https:\/\/doi.org\/10.1200\/JCO.2017.77.6310.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"9657_CR8","doi-asserted-by":"publisher","unstructured":"Siddharth S, Sharma D. Racial disparity and triple-negative breast cancer in African-American women: a multifaceted affair between obesity, biology, and socioeconomic determinants. Cancer. 2018;10(12). https:\/\/doi.org\/10.3390\/cancers10120514.","DOI":"10.3390\/cancers10120514"},{"key":"9657_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.clon.2017.06.003","volume":"29","author":"H Cain","year":"2017","unstructured":"Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM. Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol. 2017;29:642\u201352. https:\/\/doi.org\/10.1016\/j.clon.2017.06.003.","journal-title":"Clin Oncol."},{"key":"9657_CR10","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1245\/s10434-015-4714-x","volume":"22","author":"PJ Graham","year":"2015","unstructured":"Graham PJ, Brar MS, Foster T, et al. Neoadjuvant chemotherapy for breast cancer: is practice changing? A population-based review of current surgical trends. Ann Surg Oncol. 2015;22:3376\u201382. https:\/\/doi.org\/10.1245\/s10434-015-4714-x.","journal-title":"Ann Surg Oncol."},{"key":"9657_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.surg.2018.03.011","volume":"164","author":"AT Knisely","year":"2018","unstructured":"Knisely AT, Michaels AD, Mehaffey JH, et al. Race is associated with completion of neoadjuvant chemotherapy for breast cancer. Surgery. 2018;164:195\u2013200. https:\/\/doi.org\/10.1016\/j.surg.2018.03.011.","journal-title":"Surgery."},{"key":"9657_CR12","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1002\/cncr.32296","volume":"125","author":"SM Walsh","year":"2019","unstructured":"Walsh SM, Zabor EC, Stempel M, Morrow M, Gemignani ML. Does race predict survival for women with invasive breast cancer? Cancer. 2019;125:3139\u201346. https:\/\/doi.org\/10.1002\/cncr.32296.","journal-title":"Cancer."},{"key":"9657_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ijrobp.2019.10.039","volume":"106","author":"OM Fayanju","year":"2020","unstructured":"Fayanju OM, Ren Y, Suneja G, et al. Nodal response to neoadjuvant chemotherapy predicts receipt of radiation therapy after breast cancer diagnosis. Int J Radiat Oncol Biol Phys. 2020;106:377\u201389. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.039.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"9657_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project protocols B-18 and B-27. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:778\u201385. https:\/\/doi.org\/10.1200\/JCO.2007.15.0235.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"9657_CR15","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/j.clbc.2017.12.013","volume":"18","author":"J Gu","year":"2018","unstructured":"Gu J, Groot G, Boden C, Busch A, Holtslander L, Lim H. Review of factors influencing women\u2019s choice of mastectomy versus breast conserving therapy in early-stage breast cancer: a systematic review. Clin Breast Cancer. 2018;18:e539\u201354. https:\/\/doi.org\/10.1016\/j.clbc.2017.12.013.","journal-title":"Clin Breast Cancer."},{"key":"9657_CR16","first-page":"290","volume":"89","author":"G Franceschini","year":"2018","unstructured":"Franceschini G, Di Leone A, Natale M, Sanchez MA, Masett R. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer. Ann Ital Chir. 2018;89:290.","journal-title":"Ann Ital Chir."},{"key":"9657_CR17","unstructured":"National Cancer Database. American College of Surgeons. Retrieved 16 September 2020 at https:\/\/www.facs.org\/quality-programs\/cancer\/ncdb."},{"key":"9657_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10585-018-9932-8","volume":"35","author":"JM Pastoriza","year":"2018","unstructured":"Pastoriza JM, Karagiannis GS, Lin J, et al. Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis. 2018;35:613\u201323. https:\/\/doi.org\/10.1007\/s10585-018-9932-8.","journal-title":"Clin Exp Metastasis."},{"key":"9657_CR19","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/JCO.2015.63.7801","volume":"33","author":"BK Killelea","year":"2015","unstructured":"Killelea BK, Yang VQ, Wang S-Y, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the National Cancer Database. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:4267\u201376. https:\/\/doi.org\/10.1200\/JCO.2015.63.7801.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"9657_CR20","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1002\/cncr.25296","volume":"116","author":"M Chavez-MacGregor","year":"2010","unstructured":"Chavez-MacGregor M, Litton J, Chen H, et al. Pathological complete response in breast cancer patients receiving anthracycline and taxane-based neoadjuvant chemotherapy: evaluating the effect of race\/ethnicity. Cancer. 2010;116:4168\u201377. https:\/\/doi.org\/10.1002\/cncr.25296.","journal-title":"Cancer."},{"key":"9657_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-015-3350-2","volume":"150","author":"JR Tichy","year":"2015","unstructured":"Tichy JR, Deal AM, Anders CK, Reeder-Hayes K, Carey LA. Race, response to chemotherapy, and outcome within clinical breast cancer subtypes. Breast Cancer Res Treat. 2015;150:667\u201374. https:\/\/doi.org\/10.1007\/s10549-015-3350-2.","journal-title":"Breast Cancer Res Treat."},{"key":"9657_CR22","doi-asserted-by":"publisher","unstructured":"Richardson LC. Patterns and trends in age-specific black-white differences in breast cancer incidence and mortality\u2013United States, 1999\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65(40). https:\/\/doi.org\/10.15585\/mmwr.mm6540a1.","DOI":"10.15585\/mmwr.mm6540a1"},{"key":"9657_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.canep.2015.07.010","volume":"39","author":"TF Akinyemiju","year":"2015","unstructured":"Akinyemiju TF, Vin-Raviv N, Chavez-Yenter D, Zhao X, Budhwani H. Race\/ethnicity and socioeconomic differences in breast cancer surgery outcomes. Cancer Epidemiol. 2015;39:745\u201351. https:\/\/doi.org\/10.1016\/j.canep.2015.07.010.","journal-title":"Cancer Epidemiol."},{"key":"9657_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/jncimonographs\/lgu020","volume":"2014","author":"JK Kish","year":"2014","unstructured":"Kish JK, Yu M, Percy-Laurry A, Altekruse SF. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) registries. JNCI Monogr. 2014;2014:236\u201343. https:\/\/doi.org\/10.1093\/jncimonographs\/lgu020.","journal-title":"JNCI Monogr."},{"key":"9657_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/jwh.2008.1127","volume":"18","author":"L Vona-Davis","year":"2009","unstructured":"Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health. 2009;18:883\u201393. https:\/\/doi.org\/10.1089\/jwh.2008.1127.","journal-title":"J Womens Health."},{"key":"9657_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","volume":"13","author":"T-A Moo","year":"2018","unstructured":"Moo T-A, Sanford R, Dang C, Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13:339\u201354. https:\/\/doi.org\/10.1016\/j.cpet.2018.02.006.","journal-title":"PET Clin."},{"key":"9657_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","journal-title":"JAMA."},{"key":"9657_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(13)70166-9.","journal-title":"Lancet Oncol."},{"key":"9657_CR29","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","volume":"23","author":"A Mamtani","year":"2016","unstructured":"Mamtani A, Barrio AV, King TA, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23:3467\u201374. https:\/\/doi.org\/10.1245\/s10434-016-5246-8.","journal-title":"Ann Surg Oncol."},{"key":"9657_CR30","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1200\/JCO.2008.16.3766","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:5220\u20136. https:\/\/doi.org\/10.1200\/JCO.2008.16.3766.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"9657_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10549-008-9940-5","volume":"113","author":"KA Meeske","year":"2009","unstructured":"Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat. 2009;113:383\u201391. https:\/\/doi.org\/10.1007\/s10549-008-9940-5.","journal-title":"Breast Cancer Res Treat."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09657-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:50:34Z","timestamp":1632444634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09657-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,14]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["9657"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09657-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2021,2,14]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The National Cancer Database (NCDB) is a joint project of the Commission on Cancer (CoC) by the American College of Surgeons and the American Cancer Society. The NCDB of the CoC and the hospitals participating in the NCDB of the CoC are the source of the de-identified data used in this study. They have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}